Reasonable candidates are patients already engaged in a supervised weight-loss programme with diet and activity in place, who understand it is adjunctive
Biomaterials Science, 11 , 78567866
A lower mechanical load due to weight loss can lead to less bone formation followed by a decrease in BMD
ForwardHealth will only consider PA requests for PCSK9 inhibitor drugs to treat the following identified clinical conditions: Clinical criteria that must be documented for approval of a PA request for lipotropics, PCSK9 inhibitor drugs for members with clinical ASCVD are all of the following: Supporting clinical information and a copy of the member's current medical records must be submitted with all PA requests for lipotropics, PCSK9 inhibitor drugs
Delta sleep-inducing peptide (DSIP): a still unresolved riddle Kovalzon VM, Strekalova TV
Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy: a long-term, randomised, double-blind, placebo-controlled study